Found: 14
Select item for more details and to access through your institution.
Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C 44 Mab-9 for Multiple Applications against Colorectal Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 4007, doi. 10.3390/ijms24044007
- By:
- Publication type:
- Article
Development of a Novel Anti−CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5535, doi. 10.3390/ijms23105535
- By:
- Publication type:
- Article
The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12246
- By:
- Publication type:
- Article
Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models.
- Published in:
- International Journal of Molecular Medicine, 2023, v. 51, n. 2, p. N.PAG, doi. 10.3892/ijmm.2023.5221
- By:
- Publication type:
- Article
Anti-EGFR monoclonal antibody 134-mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 46, n. 4, p. 1443
- By:
- Publication type:
- Article
Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (C 9 Mab-24) Using the 1× Alanine and 2× Alanine-Substitution Method.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 11, doi. 10.3390/antib12010011
- By:
- Publication type:
- Article
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model.
- Published in:
- Antibodies (2073-4468), 2022, v. 11, n. 4, p. 74, doi. 10.3390/antib11040074
- By:
- Publication type:
- Article
Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry.
- Published in:
- Antibodies (2073-4468), 2022, v. 11, n. 4, p. 75, doi. 10.3390/antib11040075
- By:
- Publication type:
- Article
Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications.
- Published in:
- Antibodies (2073-4468), 2022, v. 11, n. 2, p. 41, doi. 10.3390/antib11020041
- By:
- Publication type:
- Article
Defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
- Published in:
- Oncology Reports, 2022, v. 48, n. 3, p. N.PAG, doi. 10.3892/or.2022.8366
- By:
- Publication type:
- Article
Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8124
- By:
- Publication type:
- Article
An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models.
- Published in:
- Oncology Reports, 2021, v. 46, n. 1, p. N.PAG, doi. 10.3892/or.2021.8083
- By:
- Publication type:
- Article
Anti-EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
- Published in:
- Oncology Reports, 2020, v. 44, n. 6, p. 2517, doi. 10.3892/or.2020.7808
- By:
- Publication type:
- Article
A defucosylated anti-CD44 monoclonal antibody 5-mG2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
- Published in:
- Oncology Reports, 2020, v. 44, n. 5, p. 1949
- By:
- Publication type:
- Article